National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

3-deazauridine
A synthetic analogue of nucleoside uridine lacking a ring nitrogen in the 3-position. 3-deazauridine inhibits cytidine synthase, thereby reducing intracellular levels of cytidine and deoxycytidine and disrupting DNA and RNA synthesis. This agent may trigger apoptosis and enhance differentiation of neoplastic cells.. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:deazauridine
Abbreviation:DAU
Chemical structure names:
  • 2(1H)-pyridinone, 4-hydroxy-1-beta-D-ribofuranosyl
  • 4-hydroxy-1-(beta-D-ribopentofuranosyl)-2-pyridone



Previous:18F-fluoromethylcholine, 18F-fluoromisonidazole, 2-methoxyestradiol, 3'-deoxy-3'-[18F]fluorothymidine, 3,4-methylenedioxymethamphetamine
Next:4'-iodo-4'-deoxydoxorubicin, 4-hydroxytamoxifen, 4-nitroestrone 3-methyl ether, 5,10-methylenetetrahydrofolate, 5-[18F]fluorouracil

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov